Delivery Order SPE2DB22D3102-SPE2DB24FL2UC

Award Date 8/30/24
Potential Completion Date 9/3/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, valued at $11,370.41, for the supply of 5% lidocaine patches. The contract has an ultimate completion date of September 30, 2024 and is not set-aside. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical commodities, including prescription drugs, vaccines, and medical supplies, to...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Lidocaine 5% Patches. The contract, valued at $1,289.82, has an ultimate completion date of September 23, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The contract has a ceiling value of $1,287.86 and a completion date of May 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Lidocaine 5% Patches. The contract, valued at $2,509.53, has a period of performance through June 28, 2024. It is a firm-fixed-price contract, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a $1,213.12 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,229,968 units of Lidocaine 5% Patches. This contract has an ultimate completion date of July 24, 2024 and is not set aside. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and...
The Defense Logistics Agency (DLA) awarded a $2,114.16 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. This contract has no set-aside designation and an ultimate completion date of September 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a $2,175.99 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Lidocaine 5% patches. The contract has an ultimate completion date of October 17, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,086.15 delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract, which has a completion date of September 11, 2024, is for the supply of Lidocaine 5% patches. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,952.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4564110488 - Lidocaine 5% Patch 30S, and has a period of performance through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of...
This is a $4,355.30 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Lidocaine 5% Patches. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB24FL2UC
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $1,620.55 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Lidocaine 5% patches. The contract has an ultimate completion date of September 3, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation, for providing a wide range of medical commodities and prescription drugs to support military, veteran, and other federal healthcare programs and facilities.

Generated 11/29/24, 9:01 AM